Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


OTC labeling rule

This article was originally published in The Tan Sheet

Executive Summary

CHPA sends questions on OTC labeling rule to FDA Office of OTC Drugs Deputy Director Linda Katz, MD, in an April 13 letter in preparation for the April 23 "feedback" meeting. Among other questions, the group inquires about breaking the Information Panel into two columns, labeling of narrow cartons and using contrasting color to meet the "box" requirement of the rule. CHPA requests the meeting include an FDA briefing on the rule. CHPA Senior VP and Director of Science & Technology William Soller, PhD, is slated to make a presentation on behalf of the association, and Thomas Donegan, VP and General Counsel for CTFA, also may speak. The meeting will take place at 9201 Corporate Blvd., Rockville, Md., from 1:30 to 3:30 p.m

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts